Literature DB >> 25634843

Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL.

Payal Kohli, David D Waters, Rita Nemr, Benoit J Arsenault, Michael Messig, David A DeMicco, Rachel Laskey, John J P Kastelein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25634843     DOI： 10.1016/j.jacc.2014.10.053

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  15 in total

1.  Association Between Statin Use and Sex Hormone in the Multi-Ethnic Study of Atherosclerosis Cohort.

Authors:  Oludamilola W Oluleye; Richard A Kronmal; Aaron R Folsom; Dhananjay M Vaidya; Pamela Ouyang; Daniel A Duprez; Adrian S Dobs; Hirad Yarmohammadi; Suma H Konety
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

2.  Statin Use and the Risk of Type 2 Diabetes Mellitus in Children and Adolescents.

Authors:  Nina R Joyce; Justin P Zachariah; Charles B Eaton; Amal N Trivedi; Gregory A Wellenius
Journal:  Acad Pediatr       Date:  2017-02-21       Impact factor: 3.107

3.  Statins Are Associated With Increased Insulin Resistance and Secretion.

Authors:  Fahim Abbasi; Cindy Lamendola; Chelsea S Harris; Vander Harris; Ming-Shian Tsai; Pragya Tripathi; Fakhar Abbas; Gerald M Reaven; Peter D Reaven; Michael P Snyder; Sun H Kim; Joshua W Knowles
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-08-26       Impact factor: 8.311

4.  Modest effect of statins on fasting glucose in a longitudinal electronic health record based cohort.

Authors:  Tanushree Haldar; Akinyemi Oni-Orisan; Thomas J Hoffmann; Catherine Schaefer; Carlos Iribarren; Ronald M Krauss; Marisa W Medina; Neil Risch
Journal:  Cardiovasc Diabetol       Date:  2022-07-14       Impact factor: 8.949

5.  Diabetes: Anti-PCSK9 antibodies - beneficial or inducers of diabetes?

Authors:  Rutger Verbeek; G Kees Hovingh
Journal:  Nat Rev Endocrinol       Date:  2017-11-09       Impact factor: 43.330

6.  Atorvastatin Induced Adverse Drug Reactions among South Indian Tamils.

Authors:  Chandrasekaran Indumathi; Natarajan Anusha; Kolar Vishwanath Vinod; Satheesh Santhosh; Steven Aibor Dkhar
Journal:  J Clin Diagn Res       Date:  2017-07-01

Review 7.  Very low LDL-C levels may safely provide additional clinical cardiovascular benefit: the evidence to date.

Authors:  Terry McCormack; Ricardo Dent; Mark Blagden
Journal:  Int J Clin Pract       Date:  2016-10-14       Impact factor: 2.503

8.  Statin use and risk of developing diabetes: results from the Diabetes Prevention Program.

Authors:  Jill P Crandall; Kieren Mather; Swapnil N Rajpathak; Ronald B Goldberg; Karol Watson; Sandra Foo; Robert Ratner; Elizabeth Barrett-Connor; Marinella Temprosa
Journal:  BMJ Open Diabetes Res Care       Date:  2017-10-10

9.  Cost-Effectiveness of Intensifying Lipid-Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients.

Authors:  Manon C Stam-Slob; Yolanda van der Graaf; Jacoba P Greving; Jannick A N Dorresteijn; Frank L J Visseren
Journal:  J Am Heart Assoc       Date:  2017-02-18       Impact factor: 5.501

10.  Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (from the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trials).

Authors:  Payal Kohli; Joshua W Knowles; Ashish Sarraju; David D Waters; Gerald Reaven
Journal:  Am J Cardiol       Date:  2016-08-12       Impact factor: 2.778
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.